182 related articles for article (PubMed ID: 29174014)
1. Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses.
Matus MF; Vilos C; Cisterna BA; Fuentes E; Palomo I
Vascul Pharmacol; 2018 Feb; 101():1-8. PubMed ID: 29174014
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
Ilinskaya AN; Dobrovolskaia MA
Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
[TBL] [Abstract][Full Text] [Related]
3. Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation.
Raghunathan S; Rayes J; Sen Gupta A
J Thromb Haemost; 2022 Jul; 20(7):1535-1549. PubMed ID: 35435322
[TBL] [Abstract][Full Text] [Related]
4. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
5. Advancement of platelet-inspired nanomedicine.
Wang S; Yuan J; Yang J; Li N; Liu R; Luan J; Ye D
Platelets; 2018 Nov; 29(7):690-694. PubMed ID: 29883255
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated-platelet-inspired nanomedicines for cancer therapy.
Geranpayehvaghei M; Dabirmanesh B; Khaledi M; Atabakhshi-Kashi M; Gao C; Taleb M; Zhang Y; Khajeh K; Nie G
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1702. PubMed ID: 33538125
[TBL] [Abstract][Full Text] [Related]
7. The role of platelets in hemostasis and the effects of snake venom toxins on platelet function.
de Queiroz MR; de Sousa BB; da Cunha Pereira DF; Mamede CCN; Matias MS; de Morais NCG; de Oliveira Costa J; de Oliveira F
Toxicon; 2017 Jul; 133():33-47. PubMed ID: 28435120
[TBL] [Abstract][Full Text] [Related]
8. Theranostic nanoparticles engineered for clinic and pharmaceutics.
Ma X; Zhao Y; Liang XJ
Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
[TBL] [Abstract][Full Text] [Related]
9. Platelet compatibility of PLGA, chitosan and PLGA-chitosan nanoparticles.
Li X; Radomski A; Corrigan OI; Tajber L; De Sousa Menezes F; Endter S; Medina C; Radomski MW
Nanomedicine (Lond); 2009 Oct; 4(7):735-46. PubMed ID: 19839810
[TBL] [Abstract][Full Text] [Related]
10. Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions.
Tomaszewski KA; Radomski MW; Santos-Martinez MJ
Nanomedicine (Lond); 2015 May; 10(9):1451-75. PubMed ID: 25996119
[TBL] [Abstract][Full Text] [Related]
11. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms.
Lanone S; Boczkowski J
Curr Mol Med; 2006 Sep; 6(6):651-63. PubMed ID: 17022735
[TBL] [Abstract][Full Text] [Related]
12. Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications.
Singh SK; Singh MK; Kulkarni PP; Sonkar VK; Grácio JJ; Dash D
ACS Nano; 2012 Mar; 6(3):2731-40. PubMed ID: 22376049
[TBL] [Abstract][Full Text] [Related]
13. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles.
Nguyen NHA; Falagan-Lotsch P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521
[TBL] [Abstract][Full Text] [Related]
15. Beyond the thrombus: Platelet-inspired nanomedicine approaches in inflammation, immune response, and cancer.
Desai C; Koupenova M; Machlus KR; Sen Gupta A
J Thromb Haemost; 2022 Jul; 20(7):1523-1534. PubMed ID: 35441793
[TBL] [Abstract][Full Text] [Related]
16. The effects of Lonomin V, a toxin from the caterpillar (Lonomia achelous), on hemostasis parameters as measured by platelet function.
Guerrero B; Arocha-Piñango CL; Salazar AM; Gil A; Sánchez EE; Rodríguez-Acosta A; Lucena S
Toxicon; 2011 Sep; 58(4):293-303. PubMed ID: 21820001
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology in Drug Delivery: Safety and Toxicity Issues.
Jain K; Mehra NK; Jain NK
Curr Pharm Des; 2015; 21(29):4252-61. PubMed ID: 26323425
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting GPIbα Shedding Preserves Post-Transfusion Recovery and Hemostatic Function of Platelets After Prolonged Storage.
Chen W; Liang X; Syed AK; Jessup P; Church WR; Ware J; Josephson CD; Li R
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1821-8. PubMed ID: 27417583
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
Li S; Shi Q; Liu G; Zhang W; Wang Z; Wang Y; Dai K
J Appl Physiol (1985); 2010 May; 108(5):1241-9. PubMed ID: 20133435
[TBL] [Abstract][Full Text] [Related]
20. Emerging nanotherapeutics for antithrombotic treatment.
Zhao Z; Yang F; Zhang X; Sun J; He Z; Luo C
Biomaterials; 2020 Oct; 255():120200. PubMed ID: 32563945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
